Mario F Scaglioni (Bruno Fuchs)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 19

Top Topics

Liver Metastases

Top Venues

Journal of clinical medicine

Diagnostics (Basel, Switzerland)

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Philip Heesen, Georg Schelling, Mirko Birbaumer, Ruben Jäger, Beata Bode, Gabriela Studer, Mario F Scaglioni, null null
Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation. Cancers 16 (14) (2024)
Philip Heesen, Maria Elyes, Jan Domanski, Georg Schelling, Sören Könneker, Mario F Scaglioni, null null
Exploring Risk Factors for Predicting 30-Day Postoperative Morbidity in Musculoskeletal Tumor Surgery. Journal of clinical medicine 13 (9) (2024)
Philip Heesen, Georg Schelling, Mirko Birbaumer, Ruben Jäger, Beata Bode, Gabriela Studer, Mario F Scaglioni, null null
Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation. Cancers 16 (14) (2024)
Philip Heesen, Maria Elyes, Jan Domanski, Georg Schelling, Sören Könneker, Mario F Scaglioni, null null
Exploring Risk Factors for Predicting 30-Day Postoperative Morbidity in Musculoskeletal Tumor Surgery. Journal of clinical medicine 13 (9) (2024)
Philip Heesen, Georg Schelling, Mirko Birbaumer, Ruben Jäger, Beata Bode, Gabriela Studer, Mario F Scaglioni, null null
Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation. Cancers 16 (14) (2024)
Georg Schelling, Philip Heesen, Boris Tautermann, Markus Wepf, Barbara Di Federico, Annika Frei, Kim van Oudenaarde, Pietro Giovanoli, Beata Bode-Lesniewska, Gabriela Studer, Mario F Scaglioni, null On Behalf Of The Swiss Sarcoma Network
Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare. Cancers 16 (12) (2024)
Timothy T A F Obergfell, Kim N Nydegger, Philip Heesen, Georg Schelling, Beata Bode-Lesniewska, Gabriela Studer, Mario F Scaglioni, null null
Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome. Cancers 16 (13) (2024)
Timothy T A F Obergfell, Kim N Nydegger, Philip Heesen, Georg Schelling, Beata Bode-Lesniewska, Gabriela Studer, Mario F Scaglioni, null null
Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome. Cancers 16 (13) (2024)
Georg Schelling, Philip Heesen, Boris Tautermann, Markus Wepf, Barbara Di Federico, Annika Frei, Kim van Oudenaarde, Pietro Giovanoli, Beata Bode-Lesniewska, Gabriela Studer, Mario F Scaglioni, null On Behalf Of The Swiss Sarcoma Network
Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare. Cancers 16 (12) (2024)
Carlo Theus-Steinmann, Georg Schelling, Philip Heesen, Stefan Breitenstein, Mario F Scaglioni, Mario F Scaglioni
How Is the Spectrum of Sarcoma Surgery Assessed? Cancers 15 (4) (2023)
Carlo Theus-Steinmann, Georg Schelling, Philip Heesen, Stefan Breitenstein, Mario F Scaglioni, Mario F Scaglioni
How Is the Spectrum of Sarcoma Surgery Assessed? Cancers 15 (4) (2023)
Mario F Scaglioni, Gabriela Studer, Beata Bode-Lesniewska, Philip Heesen, null On Behalf Of The Swiss Sarcoma Network
The Next Frontier in Sarcoma Care: Digital Health, AI, and the Quest for Precision Medicine. Journal of personalized medicine 13 (11) (2023)
Maria Elyes, Philip Heesen, Georg Schelling, Beata Bode-Lesniewska, Gabriela Studer, Mario F Scaglioni, null null
Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis. Cancers 15 (19) (2023)
Carlo Theus-Steinmann, Georg Schelling, Philip Heesen, Stefan Breitenstein, Mario F Scaglioni, Mario F Scaglioni
How Is the Spectrum of Sarcoma Surgery Assessed? Cancers 15 (4) (2023)
Markus Schärer, Philip Heesen, Beata Bode-Lesniewska, Gabriela Studer, Mario F Scaglioni, null null
Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data. Cancers 15 (24) (2023)
Mario F Scaglioni, Georg Schelling, Maria Elyes, Gabriela Studer, Beata Bode-Lesniewska, Mario F Scaglioni, Pietro Giovanoli, Philip Heesen, null On Behalf Of The SwissSarcomaNetwork
Unlocking the Power of Benchmarking: Real-World-Time Data Analysis for Enhanced Sarcoma Patient Outcomes. Cancers 15 (17) (2023)
Markus Schärer, Philip Heesen, Beata Bode-Lesniewska, Gabriela Studer, Mario F Scaglioni, null null
Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data. Cancers 15 (24) (2023)
Nasian Mosku, Philip Heesen, Salome Christen, Mario F Scaglioni, Beata Bode, Gabriela Studer, Bruno Fuchs, null null
The Sarcoma-Specific Instrument to Longitudinally Assess Health-Related Outcomes of the Routine Care Cycle. Diagnostics (Basel, Switzerland) 13 (6) (2023)
Nasian Mosku, Philip Heesen, Salome Christen, Mario F Scaglioni, Beata Bode, Gabriela Studer, Bruno Fuchs, null null
The Sarcoma-Specific Instrument to Longitudinally Assess Health-Related Outcomes of the Routine Care Cycle. Diagnostics (Basel, Switzerland) 13 (6) (2023)